(Q44414157)

English

c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones

scientific article published on May 2, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones (English)

1 reference

10.1016/S0006-291X(03)00599-0

https://api.crossref.org/works/10.1016/S0006-291X(03)00599-0

27 December 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711314

27 December 2023

transcriptional activation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711314

27 December 2023

1 reference

10.1016/S0006-291X(03)00599-0

https://api.crossref.org/works/10.1016/S0006-291X(03)00599-0

27 December 2023

1 reference

10.1016/S0006-291X(03)00599-0

https://api.crossref.org/works/10.1016/S0006-291X(03)00599-0

27 December 2023

1 reference

10.1016/S0006-291X(03)00599-0

https://api.crossref.org/works/10.1016/S0006-291X(03)00599-0

27 December 2023

Hans-Ulrich Häring

4

object named as

Hans U Häring

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

object named as

Cora Weigert

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Erwin Schleicher

5

object named as

Erwin D Schleicher

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Angelika Bierhaus

3

object named as

Angelika Bierhaus

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Katrin Brodbeck

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Hans U. Häring

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711314

27 December 2023

Erwin D. Schleicher

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711314

27 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2 May 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711314

27 December 2023

full work available at URL

https://api.elsevier.com/content/article/PII:S0006291X03005990?httpAccept=text/xml

1 reference

10.1016/S0006-291X(03)00599-0

https://api.crossref.org/works/10.1016/S0006-291X(03)00599-0

27 December 2023

https://api.elsevier.com/content/article/PII:S0006291X03005990?httpAccept=text/plain

1 reference

10.1016/S0006-291X(03)00599-0

https://api.crossref.org/works/10.1016/S0006-291X(03)00599-0

27 December 2023

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

304

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

301-307

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Unraveling the mechanism of action of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Inhibition of oxidation of low density lipoprotein by troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Troglitazone has a scavenging effect on reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Repression of glucagon gene transcription by peroxisome proliferator-activated receptor gamma through inhibition of Pax6 transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900599-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-291X(03)00599-0

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44414157&oldid=2037960527"